Bilberry for Eye & Vision

Eye and Vision — scientific infographic poster

No supplement claim is repeated more confidently, or supported more weakly, than the idea that bilberry sharpens night vision because Royal Air Force pilots ate it to see German bombers in the dark. The story is almost certainly false — most likely an offshoot of Second World War misdirection meant to hide the use of airborne radar — and the most rigorous placebo-controlled trials that tested it found no benefit in healthy eyes. This page tells that story straight, then does something more useful: it lays out the eye research that does hold up. Bilberry anthocyanins have modest controlled-trial evidence for relieving eye fatigue in screen workers, one small positive trial in dry eye, and animal research on protecting the delicate retinal microvasculature in diabetes. The honest summary is that bilberry is not night-vision goggles in a capsule, but it is not nothing either.

Table of Contents

  1. The RAF Night-Vision Legend — What Actually Happened
  2. What the Controlled Trials Found (Mostly Nothing)
  3. The One Positive Night-Vision Signal
  4. Eye Fatigue and Accommodation in Screen Workers
  5. Dry Eye
  6. The Retinal Microvasculature and Diabetic Retinopathy
  7. How Anthocyanins Might Act in the Eye
  8. What the Evidence Shows Bilberry Can and Cannot Do
  9. Cautions
  10. Key Research Papers
  11. External Authoritative Resources
  12. Connections
  13. Featured Videos

The RAF Night-Vision Legend — What Actually Happened

The story goes like this: during the Second World War, Royal Air Force night-fighter pilots developed an uncanny ability to spot and shoot down German aircraft in darkness after eating bilberry jam before missions, and the humble British berry was the secret behind their success. It is a wonderful story. It is also, as far as any historian can tell, propaganda.

What the RAF actually had was airborne interception radar — a genuinely secret, war-winning technology fitted to night fighters such as the Bristol Beaufighter. The Air Ministry needed a cover story to explain how pilots like John "Cat's Eyes" Cunningham were finding enemy bombers in the dark, without revealing that they were tracking them on a radar scope. A tale about pilots eating carrots (rich in Vitamin A, a real requirement for the light-sensing chemistry of the retina) and, in the British telling, bilberries, served that purpose beautifully. It even had the side benefit of nudging a rationed public toward home-grown vegetables. The carrot version is well documented as wartime disinformation; the bilberry version is the same legend in a different fruit.

Two things are worth separating here. First, the historical claim — that the RAF used bilberry to improve pilots' night vision — has no credible documentary support and every hallmark of a cover story. Second, the biological claim that grew out of it — that bilberry anthocyanins meaningfully improve dark adaptation or night vision in healthy people — is a testable scientific hypothesis, and it has been tested many times. The next section is what those tests found.

It is easy to see why the idea took hold. Bilberries really are packed with anthocyanins, anthocyanins really are antioxidants, and the retina really does depend on Vitamin-A-based chemistry (the rhodopsin cycle) to see in low light. The leap from "plausible" to "proven," though, is exactly the leap the evidence does not let us make.

Back to Table of Contents

What the Controlled Trials Found (Mostly Nothing)

The most important document on this subject is a systematic review by Canter and Ernst, published in Survey of Ophthalmology in 2004. They identified 30 trials of bilberry anthocyanosides with outcomes relevant to vision in reduced light; twelve were placebo-controlled, and eleven of those twelve tested healthy people with normal or above-average eyesight. The four most recent trials were all randomised controlled trials, and all four reported no effect on night vision. A fifth randomised trial and seven non-randomised controlled trials reported positive effects, but the negative results came from the more rigorous studies (the reviewers noted they also used lower doses and extracts from different sources). The authors concluded that the hypothesis that bilberry improves normal night vision is not supported by evidence from rigorous clinical studies, and that no rigorous research had tested people with impaired night vision from eye disease.

Two individual studies are worth naming because they are the ones the review leaned on:

The pattern extends beyond bilberry to close relatives. A well-designed pair of placebo-controlled crossover studies by Kalt and colleagues (2014) tested blueberry anthocyanins (n = 72 and n = 59) on dark adaptation, night vision, and the recovery of vision after a bright bleaching flash. Neither dark adaptation nor night vision improved; recovery of visual acuity after photobleaching was faster with anthocyanins in both trials, though the authors note it is not known whether that affects everyday vision. The research on black currant anthocyanosides (Nakaishi and colleagues, 2000) is more mixed, with some reported effects on dark adaptation and on screen-work-induced eye strain, but these are small studies and a different berry.

The bottom line of the best-quality evidence is that, in people with healthy eyes and normal night vision, bilberry did not improve seeing in the dark. Marketing it primarily for that purpose rests on folklore rather than on trial results.

Back to Table of Contents

The One Positive Night-Vision Signal

Science is rarely tidy, and there is one interesting exception worth reporting honestly. A 2005 study by Lee and colleagues in the British Journal of Nutrition randomised 60 people with myopia (short-sightedness) and eye strain (asthenopia) to a purified, high-dose anthocyanoside oligomer or placebo twice daily for four weeks, and reported improvements in nocturnal contrast sensitivity and in subjective symptoms compared with placebo.

This does not resurrect the RAF legend, and it is important not to overstate it. The effect was seen in people with an underlying refractive problem, not in the general population; the product was a concentrated purified oligomer rather than ordinary bilberry extract; and it is a single trial that has not been convincingly replicated at scale. But it does suggest the possibility that in eyes that are already strained — by myopia, by fatigue, by microvascular disease — anthocyanins may do something detectable, even though they do nothing measurable in healthy, rested eyes. That distinction, between the healthy eye and the stressed eye, turns out to be the thread that runs through the rest of the credible bilberry-and-eye research.

Back to Table of Contents

Eye Fatigue and Accommodation in Screen Workers

The most defensible modern eye claim for bilberry is not about darkness at all — it is about the tired, aching, blurred-at-the-end-of-the-day feeling of eyes that have spent hours locked onto a screen. This is asthenopia (eye fatigue), and it is bound up with the workload on the ciliary muscle, the tiny ring of muscle that changes the shape of the lens to keep near objects in focus (accommodation).

Ozawa and colleagues (2015) ran a randomised, double-blind, placebo-controlled trial of bilberry extract (480 mg a day for eight weeks) in office workers aged 20–40 who used video display terminals; 80 of the 88 enrolled completed it. After eight weeks, the screen-work-induced drop in critical flicker fusion (an objective measure of visual fatigue) was smaller in the bilberry group, while near-point accommodation did not differ. Five subjective symptoms — fatigue sensation, eye pain, eye heaviness, discomfort, and foreign-body sensation — eased more with bilberry than with placebo.

Kosehira and colleagues (2020), publishing in Nutrients, randomised 109 healthy adults aged 20–60 to 240 mg of standardised bilberry extract or placebo once daily for twelve weeks and measured an objective index of ciliary muscle tension (the HFC-1 value) after screen tasks. Values after the task were significantly better in the bilberry group at weeks 8 and 12, suggesting less sustained strain on the focusing muscle. Two of the three authors were employees of the extract's manufacturer. Together, these two trials are the strongest eye evidence bilberry has.

The practical read: for the specific, common, modern complaint of screen-related eye fatigue, bilberry has real (if modest) controlled-trial support. This is a world away from the night-vision myth, and it is worth keeping the two claims firmly separated.

Back to Table of Contents

Dry Eye

Dry-eye disease — the gritty, burning, watering-then-drying cycle that affects a large share of older adults and screen users — has also been studied with a standardised bilberry extract. Riva and colleagues (2017), whose first author worked for the extract's manufacturer, randomised 22 people with dry-eye symptoms to a standardised bilberry extract or placebo for four weeks (21 completed). Tear secretion on Schirmer's test improved significantly in the bilberry group, with no significant change in the placebo group, and a blood measure of antioxidant potential also rose.

This is a single, very small trial with a commercial extract, so the result is best read as promising rather than settled, and bilberry was not tested as a replacement for the mainstay treatments for dry eye (artificial tears, lid hygiene, treating the underlying inflammation, and addressing screen habits). But it fits the same "stressed eye" pattern as the fatigue research: where the ocular surface and its microcirculation are under strain, anthocyanins seem more likely to register a benefit than in a healthy resting eye. The Dry-Eye Disease page covers the condition and its first-line management in depth.

Back to Table of Contents

The Retinal Microvasculature and Diabetic Retinopathy

The retina is fed by some of the smallest, most delicate blood vessels in the body, and in diabetes those vessels are the first to fail — leaking, closing off, and eventually driving diabetic retinopathy, a leading cause of blindness in working-age adults. This is the arena where bilberry's vascular chemistry (covered in depth on the Circulation & Veins page) and its eye interest overlap.

Kim and colleagues (2015), publishing in the International Journal of Food Sciences and Nutrition, showed in diabetic rats given 100 mg/kg of Vaccinium myrtillus extract for six weeks that the extract reduced retinal leakage and prevented or delayed the breakdown of the blood-retinal barrier — the tight seal that normally keeps fluid and blood components out of retinal tissue and whose failure is a central event in diabetic macular edema. The extract also reduced retinal VEGF and preserved the tight-junction proteins (zonula occludens-1, occludin, claudin-5) that seal the microvessels, without lowering blood sugar. This echoes the vascular-permeability work in hypertensive rats (Detre and colleagues, 1986) discussed on the Circulation page.

Two honest caveats matter enormously here. First, this is animal and mechanistic evidence, not a demonstration that bilberry prevents or treats diabetic retinopathy in people. Second, diabetic retinopathy is a sight-threatening disease whose established care is ophthalmic — screening, laser, anti-VEGF injections when indicated, and above all good diabetes control. The research places bilberry at most as a supportive nutritional adjunct within that framework, not a substitute for it. The Diabetic Retinopathy page covers what has been shown to protect sight in diabetes.

Back to Table of Contents

How Anthocyanins Might Act in the Eye

If bilberry does anything useful for the eye, three overlapping mechanisms are the usual candidates, and it is worth being clear about which are established and which are hypothetical.

  1. Microvascular protection (best supported) — anthocyanins reduce capillary permeability and reinforce the collagen and basement membrane of small vessels. In a tissue as vascular as the retina, steadier, less leaky microvessels is a plausible route to benefit, and it links the retinal-barrier and diabetic-retinopathy research directly to bilberry's traditional venotonic use.
  2. Antioxidant defence of the retina (plausible) — the retina is bathed in light and oxygen and is one of the most oxidatively stressed tissues in the body. Anthocyanins are antioxidants, and reducing oxidative load on retinal cells is a reasonable mechanism, though hard to prove is doing the work in any given trial.
  3. Faster rhodopsin regeneration (the original hypothesis, weakly supported) — the night-vision folklore rested on the idea that anthocyanins speed the regeneration of rhodopsin, the light-sensing pigment in rod cells. Some early laboratory work suggested such an effect, but as the controlled human trials above showed, whatever happens in a test tube does not translate into better night vision in healthy people.

The shift in thinking over the last two decades has been away from the rhodopsin story and toward the microvascular one. That is why the surviving credible eye claims — fatigue, dry eye, diabetic retinal protection — are all, at heart, claims about blood flow and vessel integrity rather than about the photochemistry of seeing in the dark.

Back to Table of Contents

What the Evidence Shows Bilberry Can and Cannot Do

Putting the evidence together, this is what the research shows for each eye claim:

Dosing, and how standardised extracts differ in the pigment they actually contain, are covered on the Sources & Extracts page. The vascular chemistry underlying most of these effects is covered on Circulation & Veins. Bilberry also sits alongside the carotenoids Lutein and Zeaxanthin, which have their own, separate eye evidence for the macula.

Back to Table of Contents

Cautions

Back to Table of Contents

Key Research Papers

  1. Canter PH, Ernst E (2004). Anthocyanosides of Vaccinium myrtillus (bilberry) for night vision — a systematic review of placebo-controlled trials. Survey of Ophthalmology — PubMed PMID: 14711439
  2. Muth ER, Laurent JM, Jasper P (2000). The effect of bilberry nutritional supplementation on night visual acuity and contrast sensitivity. Alternative Medicine Review — PubMed PMID: 10767671
  3. Zadok D, Levy Y, Glovinsky Y (1999). The effect of anthocyanosides in a multiple oral dose on night vision. Eye (London) — PubMed PMID: 10707135
  4. Kalt W, McDonald JE, Fillmore SA, Tremblay F (2014). Blueberry effects on dark vision and recovery after photobleaching: placebo-controlled crossover studies. Journal of Agricultural and Food Chemistry — PubMed PMID: 25335781
  5. Lee J et al. (2005). Purified high-dose anthocyanoside oligomer administration improves nocturnal vision and clinical symptoms in myopia subjects. British Journal of Nutrition — PubMed PMID: 16022759
  6. Ozawa Y et al. (2015). Bilberry extract supplementation for preventing eye fatigue in video display terminal workers. Journal of Nutrition, Health & Aging — PubMed PMID: 25923485
  7. Kosehira M, Machida N, Kitaichi N (2020). A 12-week-long intake of bilberry extract (Vaccinium myrtillus L.) improved objective findings of ciliary muscle contraction of the eye: a randomized, double-blind, placebo-controlled, parallel-group comparison trial. Nutrients — PubMed PMID: 32106548
  8. Riva A, Togni S, Franceschi F et al. (2017). The effect of a natural, standardized bilberry extract (Mirtoselect) in dry eye: a randomized, double-blind, placebo-controlled trial. European Review for Medical and Pharmacological Sciences — PubMed PMID: 28617532
  9. Nakaishi H, Matsumoto H, Tominaga S, Hirayama M (2000). Effects of black currant anthocyanoside intake on dark adaptation and VDT work-induced transient refractive alteration in healthy humans. Alternative Medicine Review — PubMed PMID: 11134978
  10. Kim J et al. (2015). Vaccinium myrtillus extract prevents or delays the onset of diabetes-induced blood-retinal barrier breakdown. International Journal of Food Sciences and Nutrition — PubMed PMID: 25582181
  11. Fındık H et al. (2024). Protective effect of Vaccinium myrtillus extract on X-ray irradiation-induced retinal toxicity. Cells Tissues Organs — PubMed PMID: 37517384
  12. Detre Z, Jellinek H, Miskulin M, Robert AM (1986). Studies on vascular permeability in hypertension: action of anthocyanosides. Clinical Physiology and Biochemistry — PubMed PMID: 3698472

PubMed Topic Searches

  1. PubMed: bilberry and night vision
  2. PubMed: bilberry and eye fatigue
  3. PubMed: bilberry and dry eye
  4. PubMed: bilberry and diabetic retinopathy
  5. PubMed: anthocyanins and dark adaptation

Back to Table of Contents

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents